NIHR South London Internship Programme – Applications now open

A new NIHR-funded internship programme, hosted by ACORN at Guy’s & St Thomas’, is now open for applications. This opportunity is ideal for those who are:

  • New to research and looking to take the first step
  • Keen to grow their research confidence
  • Involved in research delivery or aspiring to lead in this area
  • Exploring a clinical academic career pathway

🗓 Cohort 1 starts January 2026
📩 Apply nowhttps://forms.office.com/e/2q82T83NQ8
📅 Deadline: Sunday 26th October 2025 at 5pm

To receive an information pack, simply send a blank email to:
📧 [email protected]

Please share with colleagues who may be interested!

 

Application guidance

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article